Abraham Ceesay, President at Cerevel Therapeutics Holdings, Inc. (CERE), sold 76,846 shares at $37.75 ($2.7M) on 2022-08-08, disclosed to the SEC on 2022-08-09.
Open-market sale of $2.7M CERE by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.50 | 38,424 | $1.2M | 45.7% |
| 2 | $37.75 | 9,606 | $363K | 13.3% |
| 3 | $37.75 | 9,606 | $363K | 13.3% |
| 4 | $39.50 | 9,605 | $379K | 13.9% |
| 5 | $39.50 | 9,605 | $379K | 13.9% |
| Total | $35.56 avg | 76,846 |
| $2.7M |
| 100% |
| Filing → |
| RAPP | SELL | 2026-08-26 | $938K | — | Filing → |
| RAPP | SELL | 2026-08-12 | $2.4M | — | Filing → |
| RAPP | SELL | 2026-07-29 | $93K | — | Filing → |